Skip to main content
Kirsten Lyke, MD, Infectious Disease, Baltimore, MD

KirstenEllizabethLykeMD

Infectious Disease Baltimore, MD

Associate Professor, Medicine, University of Maryland School of Medicine

Are you Dr. Lyke?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 89 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    22 S Greene St
    Baltimore, MD 21201
    Phone+1 410-328-5793
    Fax+1 410-328-0248

Summary

  • Dr. Kirsten Lyke, MD is an infectious disease specialist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and Arizona. She is affiliated with Veterans Affairs Maryland Health Care System-Baltimore Division and University of Maryland Medical Center.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 2001
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1992 - 1995
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1992

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1998 - 2026
  • AZ State Medical License
    AZ State Medical License 1996 - 1999
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Building a Biomedical Research Enterprise That Leads to More Equity and Healthier Lives
    Building a Biomedical Research Enterprise That Leads to More Equity and Healthier LivesOctober 28th, 2024
  • Small Study Shows Promise for Antimalarial Monoclonal Antibody to Prevent Malaria
    Small Study Shows Promise for Antimalarial Monoclonal Antibody to Prevent MalariaJanuary 26th, 2023
  • A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults
    A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African AdultsDecember 22nd, 2022
  • Join now to see all

Grant Support

  • Immunologic Determinants Of Schistosoma-Mediated Resistance To Malaria In HumansNational Institute Of Allergy And Infectious Diseases2008–2011
  • Immunologic Interaction Of Schistomiasis &Acute MalariaNational Institute Of Allergy And Infectious Diseases2002–2005